Search results

Order by most recent / most popular / relevance

Results: 1-8 of 8

The American Taxpayer Relief Act of 2012 and anticipated Medicare and Medicaid payment reforms

McDermott Will & Emery
-
USA
-
January 8 2013

On January 1, 2013, the U.S. Congress approved the American Taxpayer Relief Act of 2012 (the Act), concluding a protracted debate on how to prevent the

New FDA draft guidance regarding financial disclosures by clinical investigators

McDermott Will & Emery
-
USA
-
July 11 2011

New recommendations recently released by the FDA demonstrate the changing environment for conflicts of interest management and emphasize the need for pharmaceutical companies, medical device manufacturers and health care providers to ensure they have internal processes that adequately anticipate and meet the baseline requirements

Fourth Circuit vacates Stark damages award; provides interpretation of key Stark Law provisions

McDermott Will & Emery
-
USA
-
April 19 2012

On March 30, 2012, the U.S. Court of Appeals for the Fourth Circuit published its long-awaited decision in the case of United States ex rel. Drakeford v. Tuomey Healthcare Sys

AAMC task force releases new guidance on managing conflicts of interest in clinical care

McDermott Will & Emery
-
USA
-
August 2 2010

On June 30, 2010, the Association of American Medical Colleges (AAMC) issued a report entitled In the Interest of Patients: Recommendations for Physician Financial Relationships and Clinical Decision Making (the 2010 AAMC Report, or the Report

HHS proposes overhaul of human subject protections for domestic clinical trials

McDermott Will & Emery
-
USA
-
July 28 2011

In an advance notice of proposed rulemaking published in the July 26, 2011, Federal Register, the U.S. Department of Health and Human Services issued a request for comments on amendments to 45 C.F.R. Part 46, Subpart A (the Common Rule) to improve protections of human subjects in research and to revise the research process to reduce burdens, delays and ambiguities for investigators

Reimbursement issues facing molecular pathology services in Calendar Year 2013 and beyond

McDermott Will & Emery
-
USA
-
November 14 2012

The Centers for Medicare & Medicaid Services recently issued final regulations and a final payment guidance that address reimbursement for laboratories furnishing molecular pathology services

CMS offers partial concession to hospitals by issuing ruling, proposed rule on Part B re-billing

McDermott Will & Emery
-
USA
-
March 28 2013

The U.S. Centers for Medicare & Medicaid Services (CMS) recently released both a "ruling" and a proposed rule intended to address growing concern

Significant proposed changes for federal health care programs in President’s fiscal year 2014 budget plan

McDermott Will & Emery
-
USA
-
April 19 2013

On April 10, 2013, President Obama released his budget proposal for fiscal year (FY) 2014 (the Budget). The President reiterated his long-standing

Search results

The American Taxpayer Relief Act of 2012 and anticipated Medicare and Medicaid payment reforms

New FDA draft guidance regarding financial disclosures by clinical investigators

Fourth Circuit vacates Stark damages award; provides interpretation of key Stark Law provisions

AAMC task force releases new guidance on managing conflicts of interest in clinical care

HHS proposes overhaul of human subject protections for domestic clinical trials

Reimbursement issues facing molecular pathology services in Calendar Year 2013 and beyond

CMS offers partial concession to hospitals by issuing ruling, proposed rule on Part B re-billing

Significant proposed changes for federal health care programs in President’s fiscal year 2014 budget plan

Current Search

Suggested Facets

Author

Workarea